Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

RA Hodgson, PJ Bedard, GB Varty, TM Kazdoba… - Experimental …, 2010 - Elsevier
Parkinson's Disease (PD) and Extrapyramidal Syndrome (EPS) are movement disorders that
result from degeneration of the dopaminergic input to the striatum and chronic inhibition of …
被引用次数：108 相关文章

Preladenant, a selective A (2A) receptor antagonist, is active in primate models of movement disorders.

RA Hodgson, PJ Bedard, GB Varty… - Experimental …, 2010 - europepmc.org
Parkinson's Disease (PD) and Extrapyramidal Syndrome (EPS) are movement disorders that
result from degeneration of the dopaminergic input to the striatum and chronic inhibition of …
[PDF] academia.edu

[PDF][PDF] Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

RA Hodgson, PJ Bedard, GB Varty… - Experimental …, 2010 - academia.edu
Robert A. Hodgson a,⁎, Paul J. Bedard b, Geoffrey B. Varty a, Tatiana M. Kazdoba a,
Therese Di Paolo c, Michael E. Grzelak a, Annamarie J. Pond a, Abdallah HadjTahar b …

[引用][C] Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

RA HODGSON, PJ BEDARD, A DARE… - Experimental …, 2010 - pascal-francis.inist.fr
Preladenant, a selective A2A receptor antagonist, is active in primate models of movement
disorders CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Preladenant, a selective A (2A) receptor antagonist, is active in primate models of movement disorders

RA Hodgson, PJ Bedard, GB Varty… - Experimental …, 2010 - pubmed.ncbi.nlm.nih.gov
Parkinson's Disease (PD) and Extrapyramidal Syndrome (EPS) are movement disorders that
result from degeneration of the dopaminergic input to the striatum and chronic inhibition of …

Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

RA Hodgson, PJ Bedard, GB Varty, TM Kazdoba… - Experimental …, 2010 - infona.pl
Parkinson's Disease (PD) and Extrapyramidal Syndrome (EPS) are movement disorders that
result from degeneration of the dopaminergic input to the striatum and chronic inhibition of …

[引用][C] Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

RA HODGSON, PJ BEDARD, GB VARTY… - Experimental …, 2010 - Elsevier